# Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China

^{*}

## Abstract

**:**

## 1. Introduction

## 2. Materials and Methods

#### 2.1. Model Ingredients

- (i)
- We estimate the cumulative number of cases in China outside Hubei province after 23 January, using a time-dependent compartmental model of the transmission dynamics.
- (ii)
- We use that number as an input to the global transportation network to generate probability distributions of the number of infected travellers arriving at destinations outside China.
- (iii)
- In a destination country, we use a Galton–Watson branching process to model the initial spread of the virus. We calculate the extinction probability of each branch initiated by a single imported case, obtaining the probability of a major outbreak as the probability that at least one branch will not go extinct.

#### 2.2. Epidemic Size in China Outside the Closed Areas of Hubei

#### 2.3. Connectivity and Case Exportation

#### 2.4. Probability of a Major Outbreak in a Country by Imported Cases

#### 2.5. Dependence of the Risk of Major Outbreaks on Key Parameters

## 3. Results

#### 3.1. Epidemic Size in China

#### 3.2. Risk of Major Outbreaks

#### 3.3. Profile of Countries Benefiting the Most From Interventions

## 4. Discussion

## Author Contributions

## Funding

## Conflicts of Interest

## Appendix A. Transmission Dynamics

## Appendix B. Calculating the Risk of Outbreaks by Importation

Parameter | Interpretation | Depends on … | Typical Range |
---|---|---|---|

C | Cumulative case number in China, outside the closed areas | properties of nCoV-2019, efficacy of Chinese control | $[100K,6000K]$ |

${R}_{\mathrm{loc}}$ | Local reproduction number in destination country | destination country | $[1,2.6]$ |

$\theta $ | Probability of a importation chance that a case from the origin travelling to and mixing into the local population of the destination country | China and destination country | $[0,0.00025]$ |

## Appendix C.

## References

- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet
**2020**, 395, 497–506. [Google Scholar] [CrossRef][Green Version] - WHO. Statement Regarding Cluster of Pneumonia Cases in Wuhan, China; World Health Organization: Geneva, Switzerland, 2020. Available online: https://www.who.int/china/news/detail/09-01-2020-who-statementregarding-cluster-of-pneumonia-cases-in-wuhan-china (accessed on 17 February 2020).
- WHO. Novel Coronavirus—Thailand (ex-China); World Health Organization: Geneva, Switzerland, 2020. Available online: https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand-ex-china/en (accessed on 17 February 2020).
- WHO. Novel Coronavirus (2019-nCoV) Situation Report—1; World Health Organization: Geneva, Switzerland, 2020. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf (accessed on 17 February 2020).
- JHU IDD Team. 2019-nCoV Global Cases by Center for Systems Science and Engineering. 2020. Available online: https://docs.google.com/spreadsheets/d/1wQVypefm946ch4XDp37uZ-wartW4V7ILdg-qYiDXUHM/edit?usp=sharing (accessed on 17 February 2020).
- CDC. 2019 Novel Coronavirus. Prevention & Treatment. Cent. Disease Control Prev.
**2020**. Available online: https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html (accessed on 17 February 2020). - NPR. Chinese Authorities Begin Quarantine Of Wuhan City As Coronavirus Cases Multiply. 2020. Available online: https://www.npr.org/2020/01/23/798789671/chinese-authorities-begin-quarantine-of-wuhan-city-as-coronavirus-cases-multiply (accessed on 17 February 2020).
- Cheng, W.C.C.; Wong, S.-C.; To, K.K.W.; Ho, P.L.; Yuen, K.-Y. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. J. Hosp. Infect.
**2020**. [Google Scholar] [CrossRef][Green Version] - Arnot, M.; Mzezewa, T. The Coronavirus: What Travelers Need to Know; The New York Times: New York, NY, USA, 2020; Available online: https://www.nytimes.com/2020/01/26/travel/Coronavirus-travel.html (accessed on 17 February 2020).
- National Health Commission of the People’s Republic of China. Work begins on mobile hospital in Wuhan. 2020. Available online: http://en.nhc.gov.cn/2020-01/29/c_76034.htm (accessed on 17 February 2020).
- National Health Commission of the People’s Republic of China. Medics flood to Hubei to fight disease. 2020. Available online: http://en.nhc.gov.cn/2020-01/29/c_76031.htm (accessed on 17 February 2020).
- Parry, J. Pneumonia in China: Lack of information raises concerns among Hong Kong health workers. BMJ
**2020**. [Google Scholar] [CrossRef][Green Version] - Moore, M.; Gelfeld, B.; Okunogbe, A.T.; Christopher, P. Identifying Future Disease Hot Spots: Infectious Disease Vulnerability Index; RAND Corporation: Santa Monica, CA, USA, 2016; Available online: https://www.rand.org/pubs/research_reports/RR1605.html (accessed on 17 February 2020).
- Bogoch, I.I.; Watts, A.; Thomas-Bachli, A.; Huber, C.; Kraemer, M.U.G.; Khan, K. Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel. J. Travel Med.
**2020**. [Google Scholar] [CrossRef] - Chinazzi, M.; Davis, J.T.; Gioannini, C.; Litvinova, M.; Pastore y Piontti, A.; Rossi, L.; Xiong, X.; Halloran, M.E.; Longini, I.M.; Vespignani, A. Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City. Lab. Model. Biol. Soc.–Techn. Syst.
**2020**. Available online: https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf (accessed on 17 February 2020). - Imai, N.; Dorigatti, I.; Cori, A.; Donnelly, C.; Riley, S.; Ferguson, N.M. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. Imper. Coll. London. 2020. Available online: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/2019-nCoV-outbreak-report-22-01-2020.pdf (accessed on 17 February 2020).
- Zhao, S.; Musa, S.S.; Lin, Q.; Ran, J.; Yang, G.; Wang, W.; Lou, Y.; Yang, L.; Gao, D.; He, D.; et al. Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. J. Clin. Med.
**2020**, 9, 388. [Google Scholar] [CrossRef] [PubMed][Green Version] - Nishiura, H.; Jung, S.-M.; Linton, N.M.; Kinoshita, R.; Yang, Y.; Hayashi, K.; Kobayashi, T.; Yuan, B.; Akhmetzhanov, A.R. The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020. J. Clin. Med.
**2020**, 9, 330. [Google Scholar] [CrossRef] [PubMed][Green Version] - Imai, N.; Cori, A.; Dorigatti, I.; Baguelin, M.; Donnelly, C.A.; Riley, S.; Ferguson, N.M. Report 3: Transmissibility of 2019-nCoV. Imper. Coll. London
**2020**. Available online: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-2019-nCoV-transmissibility.pdf (accessed on 17 February 2020). - Riou, J.; Althaus, C.L. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRχiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Liu, T.; Hu, J.; Kang, M.; Lin, L.; Zhong, H.; Xiao, J.; He, G.; Song, T.; Huang, Q.; Rong, Z.; et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRχiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Read, J.M.; Bridgen, J.R.E.; Cummings, D.A.T.; Ho, A.; Jewell, C.P. Novel coronavirus 2019-nCoV: Early estimation of epidemiological parameters and epidemic predictions. medRχiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Majumder, M.; Mandl, K.D. Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China. SSRN
**2020**. [Google Scholar] [CrossRef] - Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N. Engl. J. Med.
**2020**. [Google Scholar] [CrossRef] [PubMed] - Kucharski, A.; Russell, T.; Diamond, C.; CMMID nCoV Working Group; Funk, S.; Eggo, R.M. Analysis of early transmission dynamics of nCoV in Wuhan. 2020. Available online: https://cmmid.github.io/ncov/wuhan_early_dynamics (accessed on 17 February 2020).
- Shen, M.; Peng, Z.; Xiao, Y.; Zhang, L. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China. bioRχiv
**2020**. Available online: https://www.biorxiv.org/content/10.1101/2020.01.23.916726v1 (accessed on 17 February 2020). - Leung, K.; Wu, J.T.; Leung, G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet
**2020**. to appear. [Google Scholar] [CrossRef][Green Version] - Backer, J.A.; Klinkenberg, D.; Wallinga, J. The incubation period of 2019-nCoV infections among travellers from Wuhan, China. medRχiv
**2020**. [Google Scholar] [CrossRef] - Linton, N.M.; Kobayashi, T.; Yang, Y.; Hayashi, K.; Akhmetzhanov, A.R.; Jung, S.-M.; Yuan, B.; Kinoshita, R.; Nishiura, H. Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data. medRχiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Zheng, Q.; Meredith, H.; Grantz, K.; Bi, Q.; Jones, F.; Lauer, S.; JHU IDD Team. Real-time estimation of the novel coronavirus incubation time. 2020. Available online: https://github.com/HopkinsIDD/ncov_incubation (accessed on 17 February 2020).
- Fisman, D.N.; Hauck, T.S.; Tuite, A.R.; Greer, A.L. An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number. PLoS ONE
**2013**, 8, 12. [Google Scholar] [CrossRef] [PubMed] - EpiRisk. Available online: http://epirisk.net (accessed on 17 February 2020).
- Quilty, B.; Clifford, S.; CMMID nCoV Working Group; Flasche, S.; Eggo, R.M. Effectiveness of airport screening at detecting travellers infected with 2019-nCoV. 2020. Available online: https://cmmid.github.io/ncov/airport_screening_report/airport_screening_preprint_2020_01_28.pdf (accessed on 17 February 2020).
- Britton, T. Stochastic epidemic models: A survey. Math. Biosci.
**2020**, 225, 24–35. [Google Scholar] [CrossRef] [PubMed] - Riley, S.; Fraser, C.; Donnelly, C.A.; Ghani, A.C.; Abu-Raddad, L.J.; Hedley, A.J.; Leung, G.M.; Ho, L.-M.; Lam, T.-H.; Thach, T.Q.; et al. Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions. Science
**2003**, 300, 1961–1966. [Google Scholar] [CrossRef] [PubMed][Green Version] - Park, S.W.; Champredon, D.; Earn, D.J.; Li, M.; Weitz, J.S.; Grenfell, B.T.; Dushoff, J. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: A new framework and applications to the novel coronavirus (2019-nCoV) outbreak. medRχiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Wearing, H.J.; Rohani, P.; Keeling, M.J. Appropriate Models for the Management of Infectious Diseases. PLoS Med.
**2005**, 2. [Google Scholar] [CrossRef] [PubMed] - Lauer, S.; Zlojutro, A.; Rey, D.; Dong, E.; JHU IDD Team; UNSW Sydney rCITI Team. Update January 31: Modeling the Spreading Risk of 2019-nCoV. 2020. Available online: https://systems.jhu.edu/research/public-health/ncov-model-2 (accessed on 17 February 2020).
- Nishiura, H.; Kobayashi, T.; Yang, Y.; Hayashi, K.; Miyama, T.; Kinoshita, R.; Linton, N.M.; Jung, S.-M.; Yuan, B.; Suzuki, A.; et al. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J. Clin. Med.
**2020**, 9, 419. [Google Scholar] [CrossRef] [PubMed][Green Version] - Bolyai Institute, University of Szeged. Risk assessment of novel coronavirus 2019-nCoV outbreaks outside China. Github
**2020**. Available online: https://github.com/zsvizi/corona-virus-2020 (accessed on 17 February 2020).

**Figure 1.**Final epidemic sizes in China, outside Hubei, with ${R}_{0}=2.1,2.6,3.1$, as a function of the time when the control function $u\left(t\right)$ reaches its maximum (in days after 23 January). Rapid implementation of the control generates much smaller case numbers. The inset shows the estimations of the ascertainment rate for the week 25–31, with average $0.063$, based on the ratio of confirmed cases and the maximum likelihood estimates of the case numbers from exportation.

**Figure 2.**(

**Left**) Risk of major outbreaks as a function of cumulative number of cases in selected countries, assuming ${R}_{\mathrm{loc}}=1.6$ and baseline connectivity to China. Other countries in South America, including Mexico, are inside the green shaded area. (

**Right**) The effects of reductions of imported case numbers (either by travel restriction or entry screening) in the USA and Canada, assuming ${R}_{\mathrm{loc}}=1.4$.

**Figure 3.**Outbreak risks for highly connected countries in Asia. Thailand and the Republic of Korea are plotted; the curves for Japan and Taiwan are in between them. (

**Left**) We plot the risk vs. the efficacy of prevented importations when the cumulative number of cases reaches 150,000. (

**Right**) C = 600,000. Black parts of the curves represent situations when the four countries are indistinguishable.

**Figure 4.**Selected European countries with high, medium, and low connectivity to China. (

**Left**) The outbreak risk is plotted assuming their baseline connectivity $\theta $, and ${R}_{\mathrm{loc}}=1.4$ for each country, as the cumulative number of cases is increasing. A significant reduction in the risks can be observed (

**Right**), where we reduced ${R}_{\mathrm{loc}}$ to 1.1 and assumed a 50% reduction in importations.

**Figure 5.**Heatmap of the outbreak risks as functions of $\theta $ and ${R}_{\mathrm{loc}}$, when C = 200,000. The arrows show the directions corresponding to the largest reductions in the risk.

**Table 1.**Published estimates of the key epidemiological parameters of 2019-nCoV. Uncertainty range is given where provided.

${\mathit{R}}_{0}$ | Incubation Period | Method of Estimation | Reference |
---|---|---|---|

2.6 (1.5–3.5) | - | Epidemic Simulations | [19] |

2.2 (1.4–3.8) | - | Stochastic Simulations | [20] |

2.9 (2.3–3.6) | 4.8 days | Exp. Growth, Max. Likelihood Est. | [21] |

2.56 (2.49–2.63) | - | Exp. Growth, Max. Likelihood Est. | [17] |

3.11 (2.3–4.1) | - | SEIR | [22] |

2.5 (2.0–3.1) | - | Incidence Decay and Exponential Adjustment model | [23] |

2.2 (1.4–3.9) | 5.2 days (4.1–7.0) | Renewal Equations | [24] |

−(1.4–4.0) | - | SEIR | [25] |

4.71 (4.5–4.9) | $5.0$ days ($4.9$–$5.1$) | Dec. 2019, SEIJR, MCMC | [26] |

2.08 (1.9–2.2) | - | Jan. 2020, SEIJR, MCMC | [26] |

2.68 (2.4–2.9) | - | SEIR, MCMC | [27] |

- | 5.8 days 4.6–7.9) | Weibull | [28] |

- | 4.6 days (3.3–5.8) | Weibull incl. Wuhan | [29] |

- | 5.0 days (4.0–5.8) | Weibull excl. Wuhan | [29] |

- | 5.1 days (4.4–6.1) | LogNormal | [30] |

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

## Share and Cite

**MDPI and ACS Style**

Boldog, P.; Tekeli, T.; Vizi, Z.; Dénes, A.; Bartha, F.A.; Röst, G.
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China. *J. Clin. Med.* **2020**, *9*, 571.
https://doi.org/10.3390/jcm9020571

**AMA Style**

Boldog P, Tekeli T, Vizi Z, Dénes A, Bartha FA, Röst G.
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China. *Journal of Clinical Medicine*. 2020; 9(2):571.
https://doi.org/10.3390/jcm9020571

**Chicago/Turabian Style**

Boldog, Péter, Tamás Tekeli, Zsolt Vizi, Attila Dénes, Ferenc A. Bartha, and Gergely Röst.
2020. "Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China" *Journal of Clinical Medicine* 9, no. 2: 571.
https://doi.org/10.3390/jcm9020571